Fund Holdings — CAXTON CORP

Total Portfolio Value:
$17.55M
Total Bought:
$1.05M
Total Sold:
$4.13M
Net Transaction:
-$3.08M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Xeris Biopharma Holdings Inc5,641,9205,113,348-528,572$13.26M$11.30M64.38%-$1.96M
Rezolute, Inc.(RZLT)1,318,9671,318,9670$1.31M$3.36M19.16%+$2.05M
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)1,3221,856+534$628.1K$971.0K5.53%+$342.8K
Berkshire Hathaway Inc DelCL B1,0351,019-16$369.3K$428.3K2.44%+$59.0K
Kyverna Therapeutics, Inc.(KYTX)015,846+15,846$0$393.6K2.24%+$393.6K
Molecular Templates Inc136,866136,8660$510.5K$306.6K1.75%-$203.9K
Mind Medicine Mindmed Inc029,065+29,065$0$273.2K1.56%+$273.2K
ABIVAX Société AnonymeADS(ABVX)16,74315,808-935$179.1K$226.1K1.29%+$46.9K
Lexeo Therapeutics, Inc.(LXEO)10,31910,3190$138.5K$161.8K0.92%+$23.3K
Compass Therapeutics, Inc.(CMPX)43,46543,4650$67.8K$86.1K0.49%+$18.3K
Adicet Bio Inc017,488+17,488$0$41.1K0.23%+$41.1K
Allakos Inc24,7100-24,710$67.5K$0—-$67.5K
Apogee Therapeutics Inc7,3530-7,353$205.4K$0—-$205.4K
Harpoon Therapeutics Inc13,1760-13,176$129.3K$0—-$129.3K
Savara Inc.(SVRA)353,4410-353,441$1.66M$0—-$1.66M
Page 1 of 1
CAXTON CORP — 13F Holdings — Q1 2024 | TickerTrail